ストックスクリーナーアプリを入手
9.455
5.76%
0.515
アフターアワーズ：
9.46
0.005
+0.05%
前日終値:
$8.94
開ける：
$9.96
24時間の取引高:
6,796
Relative Volume:
0.33
時価総額：
$14.53M
収益：
$630.00K
当期純損益:
$5.72M
株価収益率:
-27.69
EPS:
-0.3415
ネットキャッシュフロー:
$-6.75M
1週間 パフォーマンス:
+4.71%
1か月 パフォーマンス:
+19.68%
6か月 パフォーマンス:
+28.81%
1年 パフォーマンス:
-3.22%
1日の値動き範囲:
$9.364
$10.17
1週間の範囲:
$8.37
$10.17
52週間の値動き範囲:
$6.51
$12.05
Addex Therapeutics Ltd Adr Stock (ADXN) Company Profile
ADXN を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
ADXN
Addex Therapeutics Ltd Adr
|
9.455 | 9.56M | 630.00K | 5.72M | -6.75M | -0.3415 |
|
VRTX
Vertex Pharmaceuticals Inc
|
391.64 | 101.35B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.00 | 58.66B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
562.27 | 59.43B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
737.56 | 44.01B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
340.70 | 36.56B | 3.81B | -644.79M | -669.77M | -6.24 |
Addex Therapeutics Ltd Adr Stock (ADXN) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-07-31 | アップグレード | H.C. Wainwright | Neutral → Buy |
Addex Therapeutics Ltd Adr (ADXN) 最新ニュース
Will V.F. Corporation (VFP) stock see valuation expansionExit Point & AI Driven Stock Movement Reports - newser.com
Lion Group (NASDAQ:LGHL) Stock Price Down 4.3% – Here’s Why - Defense World
Addex Therapeutics (NASDAQ:ADXN) Shares Down 6.5% – What’s Next? - Defense World
Are Medical Stocks Lagging ADMA Biologics (ADMA) This Year? - MSN
Can trapped investors hope for a rebound in Vine Hill Capital Investment Corp.Quarterly Profit Report & Pattern Based Trade Signal System - newser.com
Applying sector rotation models to Quipt Home Medical Corp.Portfolio Profit Report & Expert Verified Stock Movement Alerts - newser.com
Is This The Best Time To Buy iSpecimen Inc (NASDAQ: ISPC) Stock? - stocksregister.com
How to read the order book for Addex Therapeutics Ltd Depositary ReceiptInsider Buying & Long Hold Capital Preservation Plans - Newser
What earnings revisions data tells us about Core Scientific Inc.Earnings Summary Report & Daily Stock Momentum Reports - Newser
Strategies to average down on Addex Therapeutics Ltd Depositary ReceiptPortfolio Return Report & Weekly High Conviction Trade Ideas - Newser
Should you hold or exit SONY nowExit Point & Intraday High Probability Setup Alerts - Newser
Can trapped investors hope for a rebound in Titan Machinery Inc.Earnings Recap Summary & AI Enhanced Execution Alerts - Newser
Real time pattern detection on Grayscale Bitcoin Mini Trust stock3-Day Market Movement Forecast Analysis - Newser
Can GSK plc ADRhedged hit a new high this monthSmart Entry Signals for Active Traders - Newser
Combining price and volume data for Flux Power Holdings Inc.Free AI Driven Stock Trend Forecast - Newser
Most active stocks: US stocks with the highest trading volume today - Yahoo.co
Addex Therapeutics (NASDAQ:ADXN) Stock Price Down 4.5% – Here’s Why - Defense World
ADR Ratio Change - Yahoo
Addex Therapeutics Reports Q1 2025 Financial Results - TipRanks
Earnings call transcript: Addex Therapeutics highlights Q1 2025 progress - Investing.com
Addex Therapeutics to Release Q1 2025 Financial Results and Host Conference Call on June 19, 2025 - GlobeNewswire Inc.
European Equities See Growth In US ADR Market - Finimize
Addex Raises $10.0 Million In Equity Financing - Barchart.com
Addex Therapeutics Earnings Call: Strategic Gains Amid Financial Challenges - TipRanks
Addex Therapeutics Reports Strong 2024 Financial Turnaround - TipRanks
META_TITLE_SECTORS - Yahoo Finance
Are Medical Stocks Lagging Addex Therapeutics (ADXN) This Year? - Nasdaq
Akebia Therapeutics (AKBA) Reports Q3 Loss, Misses Revenue Estimates - Yahoo Finance
Are Medical Stocks Lagging Boston Scientific (BSX) This Year? - Yahoo Finance
What Makes Addex Therapeutics (ADXN) a New Buy Stock - Nasdaq
Addex Stock Soars on Crucial Update From Indivior Research Deal - Nasdaq
Is Boston Scientific (BSX) Stock Outpacing Its Medical Peers This Year? - Nasdaq
Earnings call: Addex Therapeutics reports on collaborations and financials - Investing.com
Esperion Therapeutics (ESPR) Reports Q3 Loss, Tops Revenue Estimates - Nasdaq
Addex Therapeutics earnings matched, revenue topped estimates - Investing.com India
Addex Therapeutics (ADXN) Stock Rallied 62.1% on Phase 2 Study - AskTraders.com
Addex Therapeutics Ltd. Sponsored ADR (ADXN) Reports Q3 Loss, Tops Revenue Estimates - Nasdaq
Le 1001 azioni che si sono schiantate sul mercato azionario USA - Scenari Economici
Addex (ADXN) Terminates Parkinson's-Related Dyskinesia Study - Nasdaq
Addex To Present At The H.C. Wainwright BIOCONNECT Virtual Conference - Barchart.com
Addex Reports Q3 2021 Financial Results And Provides Corporate Update - Barchart.com
Addex Therapeutics (ADXN) Stock Price, News & Analysis - MarketBeat
The Daily Biotech Pulse: AbbVie, Allergan Agree On Divestments, Obalon Stops Obesity Balloon Sale, COVID-19 Updates - Yahoo Finance
ADXN Stock Price and Chart — SIX:ADXN - TradingView
Addex Therapeutics Ltd Adr (ADXN) 財務データ
収益
当期純利益
現金流量
EPS
2.36%
1.10%
大文字化:
|
ボリューム (24 時間):